1 unchanged sentence
We currently lease a total of approximately 364,445 square feet of building space in Salt Lake City dedicated to research and development, administration and our laboratory that has received federal certification under CLIA.
−Removed: Activities related to our oncology, urology, and women’s health molecular diagnostic business are performed at this location.
−Removed: The leases on our existing Salt Lake City facilities have terms of five to fifteen years, expiring from 2025 through 2036, and provide for renewal options for up to ten additional years.
−Removed: We also lease approximately 93,000 square feet in South San Francisco, California under two leases that expire in April 2025 and September 2025.
−Removed: This space is dedicated to administration, research and development and the CLIA-certified laboratory for our Women’s Health business.
+Added: Activities related to our Oncology and Women’s Health businesses are performed at this location.
+Added: The leases on our existing Salt Lake City facilities have terms of ten to fifteen years, expiring from 2027 through 2038, and provide for renewal options for up to ten additional years.
+Added: We currently lease a total of approximately 111,635 square feet of building space in South San Francisco, California dedicated to administration, research and development and the CLIA-certified laboratory for our Women’s Health business.
+Added: The leases on our existing South San Francisco facilities have terms of seven to ten years, expiring from 2025 through 2033, and provide for renewal options for up to ten additional years.
We also lease a space in Mason, Ohio, with approximately 24,000 total square feet, which will expire in August 2024.
−Removed: In addition, in late 2021, we entered into a non-cancelable operating lease for approximately 63,000 square feet in South San Francisco, California, which will commence in 2023 and expire in 2033.
−Removed: In the first quarter of 2022, we entered into a non-cancelable operating lease for approximately 230,000 square feet in Salt Lake City, Utah, which will commence in 2022 and expire in 2038.
+Added: Our GeneSight test is performed at this location in a CLIA-certified laboratory.
We also lease several small office locations, including our manufacturing facility located in Cologne, Germany.
We believe that our existing facilities and equipment are well maintained and in good working condition.
−Removed: We believe our current facilities and those planned will provide adequate capacity for the foreseeable future.
−Removed: We continue to make investments in capital equipment as needed to meet the anticipated demand for our molecular diagnostic tests.
+Added: We believe our current facilities and those planned in South San Francisco and San Diego, California and west Salt Lake City, Utah will provide adequate capacity for the foreseeable future.
+Added: For more information on our leased properties, see "Note 13-Leases in the Notes to Consolidated Financial Statements."
+Added: LEGAL PROCEEDINGS
+Added: For information regarding certain current legal proceedings, see "Note 12--Commitments and Contingencies in the Notes to Consolidated Financial Statements."
+Added: MINE SAFETY DISCLOSURES
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.